Moxonidine Cas No: 75438-57-2

XiA an Wanlong pharmaceutical Co., Ltd was founded in 1995 and it is comprehensive modern pharmaceutical enterprise which mainly produces formulations, API and intermediates. The companyA s registered capital reaches CNY 75 million. The building area of company is over 2000000 square meters. All the work shops are compliant with GMP requirements. There are more than 700 employees including over 70 RD staffs20 experienced production management people and 8 senior professional registration specialists. Having a dynamic, high-quality team, which ensures our company sustainable and stable development. We produce tablets, capsule, granules, injection and API, total 49 drug approval numbers and other intermediates. There are 4 API workshops, and two solid preparation plants, injection plants with GMP. Annual production capacity of 100 tons of raw material, solid dosage form annual output of 3 billion, injection annual output 1.3 billion bags. The drug products are widely used in the most provinces of china, and API exports to all over the world. We have the rights of self-operated import and export and welcome the clients around the world to cooperate with us.